| Not Yet Recruiting | A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 3 | 2026-06-08 |
| Recruiting | A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Can Non-Muscle Invasive Bladder Neoplasms | — | 2026-04-30 |
| Not Yet Recruiting | A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2026-04-20 |
| Recruiting | A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 3 | 2026-03-05 |
| Recruiting | A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2026-03-03 |
| Recruiting | A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2026-02-08 |
| Recruiting | A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Partici Multiple Myeloma | Phase 3 | 2026-02-04 |
| Recruiting | A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2026-01-20 |
| Recruiting | A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies Lymphoma, Non-Hodgkin | Phase 1 | 2026-01-20 |
| Withdrawn | A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis Lupus Nephritis | Phase 2 | 2026-01-15 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psor Arthritis, Psoriatic | Phase 2 | 2026-01-15 |
| Recruiting | A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer Prostatic Neoplasms | Phase 1 | 2026-01-14 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disord Depressive Disorder, Major | Phase 3 | 2026-01-08 |
| Recruiting | Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis Myasthenia Gravis | Phase 3 | 2026-01-05 |
| Withdrawn | A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participan Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | 2025-12-26 |
| Recruiting | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Pro Prostatic Neoplasms, Castration-Resistant | Phase 3 | 2025-12-19 |
| Recruiting | A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry Hemolytic Disease of the Fetus and Newborn | — | 2025-12-17 |
| Recruiting | A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting Arthritis, Psoriatic | — | 2025-12-04 |
| Recruiting | A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in Carcinoma, Non-Small-Cell Lung | — | 2025-12-03 |
| Recruiting | A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants Wi Squamous Cell Carcinoma of Head and Neck | Phase 3 | 2025-12-03 |
| Recruiting | A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants Depressive Disorder, Major | — | 2025-11-24 |
| Recruiting | A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia Acute Lymphoblastic Leukemia, Acute Leukemias, Acute Myeloid Leukemia | Phase 1 | 2025-11-18 |
| Recruiting | A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors Advanced-stage Solid Tumors | Phase 1 | 2025-10-10 |
| Recruiting | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 2 / Phase 3 | 2025-10-03 |
| Recruiting | A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel Multiple Myeloma | Phase 2 | 2025-10-03 |
| Recruiting | A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulce Colitis, Ulcerative | Phase 3 | 2025-10-01 |
| Recruiting | A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Musc Non-Muscle Invasive Bladder Neoplasms | Phase 3 | 2025-09-10 |
| Recruiting | A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) Metastatic Castration-resistant Prostate Neoplasms | Phase 3 | 2025-09-02 |
| Recruiting | A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors Colorectal Neoplasms | Phase 1 | 2025-07-15 |
| Recruiting | A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer Prostatic Neoplasms | Phase 1 | 2025-07-07 |
| Recruiting | A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Mye Leukemia, Myeloid, Acute | Phase 3 | 2025-06-04 |
| Active Not Recruiting | A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Plaque Psoriasis | Phase 3 | 2025-04-15 |
| Recruiting | A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms Leukemia, Myeloid, Acute, Myelodysplastic Neoplasms | Phase 1 | 2025-03-21 |
| Active Not Recruiting | A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) Dermatitis, Atopic | Phase 2 | 2025-02-26 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Arthritis, Psoriatic | Phase 3 | 2025-02-21 |
| Recruiting | A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloi Thrombocytopenia, Neonatal Alloimmune | Phase 3 | 2025-02-10 |
| Recruiting | A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms Leukemia, Myeloid, Acute, Myelodysplastic Neoplasms | Phase 1 | 2025-01-14 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants Arthritis, Psoriatic | Phase 3 | 2025-01-09 |
| Enrolling By Invitation | A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | 2024-12-30 |
| Recruiting | A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder Depressive Disorder, Major | Phase 2 | 2024-12-26 |
| Recruiting | A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 | 2024-12-19 |
| Recruiting | A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemo Carcinoma, Non-Small-Cell Lung | Phase 2 | 2024-12-16 |
| Recruiting | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and Colorectal Neoplasms | Phase 3 | 2024-12-12 |
| Active Not Recruiting | Nipocalimab in Moderate to Severe Sjogren's Disease Sjogrens Syndrome | Phase 3 | 2024-12-04 |
| Recruiting | A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Po Multiple Myeloma | Phase 1 | 2024-12-04 |
| Recruiting | A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Thrombocytopenia, Neonatal Alloimmune | Phase 3 | 2024-11-11 |
| Recruiting | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic | Phase 3 | 2024-10-29 |
| Active Not Recruiting | A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory Lymphoma, Non-Hodgkin | Phase 1 | 2024-10-22 |
| Recruiting | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatmen Colorectal Neoplasms | Phase 3 | 2024-10-18 |
| Recruiting | A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers Colorectal Neoplasms, Gastrointestinal Neoplasms | Phase 1 | 2024-10-15 |
| Active Not Recruiting | A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked X-Linked Retinitis Pigmentosa | Phase 2 | 2024-10-10 |
| Recruiting | A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrop Geographic Atrophy, Macular Degeneration | Phase 2 | 2024-09-19 |
| Terminated | A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Maj Depressive Disorder, Major, Anhedonia | Phase 3 | 2024-09-19 |
| Active Not Recruiting | A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Multiple Myeloma | Phase 2 | 2024-09-16 |
| Recruiting | A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events Multiple Myeloma | Phase 2 | 2024-08-26 |
| Active Not Recruiting | A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Co Multiple Myeloma | Phase 2 | 2024-08-20 |
| Recruiting | Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Depressive Disorder, Major | Phase 3 | 2024-07-25 |
| Active Not Recruiting | A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell L Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2024-07-23 |
| Terminated | A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) W Depressive Disorder, Major, Anhedonia | Phase 3 | 2024-06-26 |
| Active Not Recruiting | A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myelom Relapsed or Refractory Multiple Myeloma | Phase 1 | 2024-06-07 |
| Recruiting | A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocyt Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma | Phase 2 | 2024-05-30 |
| Active Not Recruiting | A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL | Phase 1 | 2024-05-28 |
| Recruiting | A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cance Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | 2024-04-22 |
| Recruiting | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Can Non-Muscle Invasive Bladder Neoplasms | Phase 3 | 2024-04-18 |
| Active Not Recruiting | A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasi Non-Muscle Invasive Bladder Neoplasms | Phase 3 | 2024-04-09 |
| Recruiting | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease Crohn's Disease | Phase 3 | 2024-03-13 |
| Active Not Recruiting | A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADV Plaque Psoriasis | Phase 3 | 2024-03-09 |
| Recruiting | Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Carcinoma, Non-Small-Cell Lung | Phase 2 | 2024-02-16 |
| Completed | A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors Advanced Stage Solid Tumors | Phase 1 | 2024-02-09 |
| Active Not Recruiting | A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2024-02-01 |
| Recruiting | A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, a Multiple Myeloma | Phase 3 | 2024-01-22 |
| Active Not Recruiting | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis Colitis, Ulcerative | Phase 3 | 2024-01-19 |
| Completed | A Study of Sterile Saline Infusion in Healthy Volunteers Healthy Volunteers | EARLY_Phase 1 | 2024-01-12 |
| Recruiting | A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms Neoplasms | Phase 1 | 2023-12-20 |
| Recruiting | A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) Hemolytic Disease of the Fetus and Newborn | Phase 3 | 2023-12-20 |
| Recruiting | A Study of JNJ-87890387 for Advanced Solid Tumors Neoplasms, Advanced Solid Tumors | Phase 1 | 2023-12-14 |
| Active Not Recruiting | A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid ( Lymphoma, Non-Hodgkin | Phase 1 | 2023-12-06 |
| Active Not Recruiting | A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL) Relapsed or Refractory B Cell Non-Hodgkin Lymphoma | Phase 1 | 2023-11-06 |
| Recruiting | A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer Advanced Prostate Cancer | Phase 1 | 2023-11-01 |
| Completed | A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent I Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention | Phase 3 | 2023-10-24 |
| Active Not Recruiting | A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp Plaque Psoriasis | Phase 3 | 2023-10-12 |
| Active Not Recruiting | A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2023-10-12 |
| Completed | A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis Colitis, Ulcerative | Phase 2 | 2023-10-09 |
| Active Not Recruiting | Global Patient Registry of Inherited Retinal Diseases Inherited Retinal Diseases | — | 2023-08-31 |
| Active Not Recruiting | A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC Metastatic Castrate-sensitive Prostate Cancer | Phase 3 | 2023-08-31 |
| Completed | Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis Moderate Plaque Psoriasis | Phase 3 | 2023-08-24 |
| Completed | A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoi Arthritis, Rheumatoid | Phase 2 | 2023-08-15 |
| Completed | A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants Healthy | Phase 1 | 2023-05-30 |
| Completed | A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge Healthy | Phase 1 | 2023-05-22 |
| Active Not Recruiting | Premedication to Reduce Amivantamab Associated Infusion Related Reactions Carcinoma, Non-Small-Cell Lung | Phase 2 | 2023-05-18 |
| Active Not Recruiting | A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2023-05-18 |
| Withdrawn | A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants Healthy | Phase 1 | 2023-05-01 |
| Active Not Recruiting | A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Depressive Disorder, Major | — | 2023-04-28 |
| Recruiting | A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer | Phase 1 | 2023-04-26 |
| Completed | A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants Healthy | Phase 1 | 2023-04-12 |
| Active Not Recruiting | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation Atrial Fibrillation | Phase 3 | 2023-04-11 |
| Completed | A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome Acute Coronary Syndrome | Phase 3 | 2023-04-07 |
| Active Not Recruiting | A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Relapsed or Refractory Multiple Myeloma | Phase 3 | 2023-03-29 |
| Active Not Recruiting | A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guéri Bladder Cancer | Phase 3 | 2023-03-23 |
| Completed | A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Ge Geographic Atrophy | Phase 2 | 2023-03-06 |
| Terminated | A Study of JNJ-64281802 for the Prevention of Dengue Infection Dengue | Phase 2 | 2023-02-22 |
| Terminated | A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection Crohn's Disease | Phase 3 | 2023-02-21 |
| Recruiting | A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LI Ischemic Stroke; Ischemic Attack, Transient | Phase 3 | 2023-02-15 |
| Completed | A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants Healthy | Phase 1 | 2023-02-14 |
| Completed | A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness Acute Respiratory Viral Infection | — | 2023-01-19 |
| Completed | A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants Healthy | Phase 1 | 2023-01-03 |
| Recruiting | A Study of Daratumumab Multiple Myeloma | Phase 3 | 2022-12-15 |
| Active Not Recruiting | A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cance Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2022-12-13 |
| Terminated | A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma Carcinoma, Hepatocellular | Phase 2 | 2022-12-08 |
| Completed | A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma Lymphoma, Mantle-Cell | Phase 2 | 2022-12-06 |
| Completed | A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to Depressive Disorder, Major, Anhedonia | Phase 3 | 2022-12-06 |
| Recruiting | A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amy Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis | Phase 1 | 2022-11-22 |
| Completed | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer Prostatic Neoplasms | Phase 1 | 2022-11-15 |
| Recruiting | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Fac Carcinoma, Non-small-Cell Lung | Phase 2 | 2022-11-11 |
| Recruiting | A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combinatio Multiple Myeloma | Phase 3 | 2022-10-25 |
| Withdrawn | A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Mye Relapsed/ Refractory Multiple Myeloma | Phase 3 | 2022-10-20 |
| Active Not Recruiting | A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidom Relapsed or Refractory Multiple Myeloma | Phase 3 | 2022-10-13 |
| Active Not Recruiting | A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies Leukemia, Myeloid, Acute | Phase 1 | 2022-10-04 |
| Recruiting | Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CI Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 2 / Phase 3 | 2022-09-23 |
| Terminated | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) Depressive Disorder, Major | Phase 3 | 2022-09-22 |
| Active Not Recruiting | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Activ Colitis, Ulcerative | Phase 2 | 2022-09-19 |
| Completed | A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants Healthy | Phase 1 | 2022-09-14 |
| Active Not Recruiting | A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis Colitis, Ulcerative | Phase 3 | 2022-09-13 |
| Withdrawn | A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Depression | Phase 1 | 2022-09-01 |
| Active Not Recruiting | A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis Arthritis, Juvenile | Phase 3 | 2022-08-30 |
| Completed | A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appe Healthy | Phase 1 | 2022-08-22 |
| Active Not Recruiting | A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With No Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | 2022-08-18 |
| Recruiting | A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse | Phase 1 / Phase 2 | 2022-08-12 |
| Active Not Recruiting | A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Advanced or Metastatic Non-small Cell Lung Cancer | Phase 3 | 2022-08-05 |
| Completed | A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet Human Immunodeficiency Virus (HIV) | Phase 1 | 2022-08-03 |
| Recruiting | A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advan Advanced or Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2022-07-29 |
| Active Not Recruiting | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Activ Crohn's Disease | Phase 2 | 2022-07-22 |
| Completed | A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment Myeloproliferative Neoplasms | Phase 1 | 2022-07-21 |
| Recruiting | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis Myasthenia Gravis | Phase 2 / Phase 3 | 2022-07-20 |
| Completed | Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis Plaque Psoriasis, Scalp Psoriasis | Phase 3 | 2022-07-13 |
| Active Not Recruiting | A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Ur Urinary Bladder Neoplasms | Phase 2 | 2022-07-07 |
| Active Not Recruiting | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies Myositis | Phase 2 | 2022-07-05 |
| Terminated | A Single and Multiple Ascending Dose Study of JNJ-64457744 Healthy, Hepatitis B, Chronic | Phase 1 | 2022-07-04 |
| Completed | An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Ce Hepatitis B, Chronic | Phase 2 | 2022-06-30 |
| Completed | A Study of JNJ-63733657 in Healthy Chinese Participants Healthy | Phase 1 | 2022-06-27 |
| Completed | A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Mo Depressive Disorder, Major, Anhedonia | Phase 3 | 2022-06-22 |
| Completed | A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2022-06-13 |
| Completed | A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2022-06-10 |
| Completed | A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to t Healthy | Phase 1 | 2022-06-07 |
| Completed | A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants Healthy | Phase 1 | 2022-05-30 |
| Completed | A Study of JNJ-80202135 in Healthy Chinese Adult Participants Healthy | Phase 1 | 2022-05-30 |
| Active Not Recruiting | A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhi Relapsed/ Refractory Multiple Myeloma | Phase 1 | 2022-05-25 |
| Completed | A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis Juvenile Psoriatic Arthritis, Psoriasis, Arthritis, Juvenile | Phase 1 | 2022-05-24 |
| Completed | A Study of Seltorexant in Participants With Probable Alzheimer's Disease Alzheimer Disease | Phase 2 | 2022-05-19 |
| Completed | A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection Hepatitis B, Chronic | Phase 1 | 2022-04-19 |
| Recruiting | Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer Non-Muscle Invasive Bladder Neoplasms | Phase 1 / Phase 2 | 2022-04-11 |
| Completed | A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer Carcinoma, Non-Small-Cell Lung | — | 2022-03-28 |
| Terminated | A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Cast Prostatic Neoplasms | Phase 1 | 2022-03-23 |
| Completed | A Study of Ustekinumab Treatment in Children With Crohn's Disease Crohn's Disease | — | 2022-03-21 |
| Recruiting | A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel Multiple Myeloma | Phase 4 | 2022-03-09 |
| Withdrawn | A Study of JNJ-70075200 in Healthy Participants Healthy | Phase 1 | 2022-03-01 |
| Active Not Recruiting | A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis Amyloidosis | Phase 2 | 2022-03-01 |
| Completed | A Study of JNJ-64281802 in Healthy Adult Participants Healthy | Phase 1 | 2022-02-23 |
| Completed | A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2022-02-03 |
| Completed | A Study of JNJ-42847922 (Seltorexant) in Healthy Participants Healthy | Phase 1 | 2022-02-03 |
| Terminated | A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever Dengue | Phase 2 | 2022-01-24 |
| Active Not Recruiting | A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2022-01-19 |
| Completed | A Study of 14C JNJ-67953964 in Healthy Adult Male Participants Healthy | Phase 1 | 2022-01-14 |
| Completed | A Study of Acute Respiratory Infections in Global Outpatient Setting Acute Respiratory Infection | EARLY_Phase 1 | 2021-12-20 |
| Completed | A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem Healthy Non-dependent, Recreational Sedative Users, Abuse Potential | Phase 1 | 2021-12-17 |
| Completed | A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir Healthy | Phase 1 | 2021-12-10 |
| Completed | A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 4 | 2021-12-10 |
| Completed | A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e An Hepatitis B, Chronic | Phase 1 | 2021-12-06 |
| Completed | A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937) Hepatic Impairment, Healthy | Phase 1 | 2021-11-30 |
| Terminated | A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection Respiratory Syncytial Virus | Phase 2 | 2021-11-17 |
| Active Not Recruiting | A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-B Carcinoma, Non-Small-Cell Lung | Phase 3 | 2021-11-17 |
| Completed | A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants Healthy | Phase 1 | 2021-11-16 |
| Completed | A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis Adenomatous Polyposis Coli | Phase 1 | 2021-11-10 |
| Terminated | A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis Arthritis, Psoriatic, Healthy | Phase 1 | 2021-11-04 |
| Terminated | A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B, Chronic | Phase 2 | 2021-11-03 |
| Completed | A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopath Pigmentary Maculopathy, Pigmentary Retinopathy, Interstitial Cystitis | — | 2021-10-26 |
| Terminated | A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a S Depressive Disorder, Major | — | 2021-10-26 |
| Completed | A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis Arthritis, Psoriatic | Phase 2 | 2021-10-25 |
| Completed | A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors Neoplasms | Phase 1 | 2021-10-24 |
| Completed | A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2021-10-18 |
| Active Not Recruiting | A Long-term Extension Study of Ustekinumab in Pediatric Participants Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic | Phase 3 | 2021-10-18 |
| Completed | A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arth Arthritis, Rheumatoid | Phase 2 | 2021-10-14 |
| Active Not Recruiting | A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, P Multiple Myeloma | Phase 3 | 2021-10-14 |
| Terminated | A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2021-10-12 |
| Active Not Recruiting | Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-T Arthritis, Psoriatic | Phase 3 | 2021-09-28 |
| Completed | A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants Prostatic Neoplasms | Phase 1 | 2021-09-28 |
| Active Not Recruiting | A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma Multiple Myeloma | Phase 1 | 2021-09-22 |
| Completed | A Study of JNJ-73763989 in Adult Participants With Renal Impairment Renal Impairment | Phase 1 | 2021-09-22 |
| Completed | A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) Sjogren's Syndrome | Phase 2 | 2021-09-21 |
| Completed | A Study of Lazertinib (JNJ-73841937) in Healthy Participants Healthy | Phase 1 | 2021-09-17 |
| Terminated | A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respirator Respiratory Tract Infections | Phase 3 | 2021-09-06 |
| Terminated | A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2021-09-02 |
| Terminated | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Depressive Disorder, Major | Phase 1 | 2021-09-02 |
| Completed | A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants Healthy | Phase 1 | 2021-08-31 |
| Active Not Recruiting | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Ax Arthritis, Psoriatic | Phase 4 | 2021-08-30 |
| Completed | A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis Psoriasis | Phase 4 | 2021-08-25 |
| Completed | A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2021-08-20 |
| Active Not Recruiting | A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Ag Multiple Myeloma | Phase 3 | 2021-08-19 |
| Completed | A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants Healthy, Hepatic Impairment | Phase 1 | 2021-08-05 |
| Completed | A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appe Healthy | Phase 1 | 2021-07-30 |
| Completed | A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | 2021-07-28 |
| Recruiting | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis Myasthenia Gravis | Phase 3 | 2021-07-15 |
| Completed | A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of Interest Healthy | EARLY_Phase 1 | 2021-07-14 |
| Active Not Recruiting | A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Prostatic Neoplasms | Phase 1 | 2021-07-13 |
| Completed | A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prev Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention | Phase 3 | 2021-06-30 |
| Completed | A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-700997 Healthy | Phase 1 | 2021-06-23 |
| Active Not Recruiting | A Study of Guselkumab in Participants With Active Psoriatic Arthritis Arthritis, Psoriatic | Phase 3 | 2021-06-17 |
| Withdrawn | A Study of Guselkumab in Adult Participants With Celiac Disease Celiac Disease | Phase 1 | 2021-06-17 |
| Terminated | A Study of JNJ-69095897 in Healthy Participants Healthy | Phase 1 | 2021-06-16 |
| Withdrawn | Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Healthy | Phase 1 | 2021-06-01 |
| Withdrawn | A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants Healthy | Phase 1 | 2021-05-30 |
| Completed | A Study of JNJ-68179280 in Healthy Participants Healthy | Phase 1 | 2021-05-26 |
| Completed | A Study of Nipocalimab in Healthy Male and Female Participants Healthy | Phase 1 | 2021-05-25 |
| Recruiting | A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2021-05-19 |
| Completed | A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy Focal Onset Seizures | Phase 2 | 2021-05-18 |
| Withdrawn | A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 2 | 2021-05-06 |
| Withdrawn | A Study of JNJ-56136379 in Healthy Participants Healthy | Phase 1 | 2021-05-06 |
| Terminated | A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatiti Dermatitis, Atopic | Phase 2 | 2021-05-03 |
| Active Not Recruiting | ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 1 | 2021-05-03 |
| Completed | A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Healthy | Phase 1 | 2021-04-30 |
| Completed | A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 Fatty Liver Disease | Phase 1 | 2021-04-29 |
| Completed | A Study of JNJ-67835989 in Healthy Participants Healthy | Phase 1 | 2021-04-27 |
| Completed | A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants Healthy | Phase 1 | 2021-04-14 |
| Completed | A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants Healthy | Phase 1 | 2021-04-14 |
| Completed | A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2021-04-06 |
| Completed | A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants Renal Impairment | Phase 1 | 2021-03-31 |
| Withdrawn | A Study of JNJ-64304500 in Participants With Alopecia Areata Alopecia Areata | Phase 2 | 2021-03-24 |
| Completed | A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) Colitis, Ulcerative | Phase 3 | 2021-03-17 |
| Active Not Recruiting | A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma Multiple Myeloma | Phase 1 | 2021-03-12 |
| Completed | A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatiti Hepatitis B | Phase 2 | 2021-03-11 |
| Completed | A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix Healthy | EARLY_Phase 1 | 2021-03-10 |
| Completed | A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants Healthy | Phase 1 | 2021-03-08 |
| Withdrawn | A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease Crohn Disease | Phase 2 | 2021-03-03 |
| Completed | A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leu Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia | Phase 1 | 2021-02-25 |
| Completed | A Study of JNJ-64300535 in Healthy Participants Healthy | Phase 1 | 2021-02-03 |
| Recruiting | A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma Hematological Malignancies | Phase 2 | 2021-02-01 |
| Completed | A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virological Hepatitis B, Chronic | Phase 2 | 2021-02-01 |
| Completed | A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Con Healthy | Phase 1 | 2021-01-26 |
| Completed | A Study to Compare Two Different Subcutaneously-administered JNJ-64304500 Formulations in Healthy Participants Healthy | Phase 1 | 2021-01-13 |
| Terminated | A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease Alzheimer Disease, Cognitive Dysfunction, Dementia | Phase 2 | 2021-01-06 |
| Completed | A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in Healthy | Phase 1 | 2021-01-05 |
| Active Not Recruiting | A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non Urinary Bladder Neoplasms | Phase 2 | 2020-12-18 |
| Active Not Recruiting | A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Multiple Myeloma | Phase 1 / Phase 2 | 2020-12-15 |
| Terminated | A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteri Giant Cell Arteritis | Phase 2 | 2020-12-10 |
| Active Not Recruiting | A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Mus Urinary Bladder Neoplasms | Phase 3 | 2020-12-07 |
| Active Not Recruiting | Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in th X-Linked Retinitis Pigmentosa | Phase 3 | 2020-12-04 |
| Completed | Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gen X-Linked Retinitis Pigmentosa | Phase 3 | 2020-12-04 |
| Completed | A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy Healthy | Phase 1 | 2020-11-30 |
| Completed | A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | 2020-11-26 |
| Completed | A Study of JNJ-73763989 in Healthy Chinese Adult Participants Healthy | Phase 1 | 2020-11-24 |
| Completed | A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | 2020-11-20 |
| Active Not Recruiting | A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer Prostatic Neoplasms | Phase 1 | 2020-11-13 |
| Active Not Recruiting | A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Pros Prostatic Neoplasms, Adenocarcinoma | Phase 1 | 2020-11-12 |
| Active Not Recruiting | A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies Neoplasms | Phase 1 | 2020-11-10 |
| Completed | A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depressive Disorder, Treatment-Resistant | Phase 4 | 2020-11-04 |
| Completed | A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appe Healthy | Phase 1 | 2020-10-27 |
| Completed | A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appe Healthy | Phase 1 | 2020-10-21 |
| Completed | A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of S Healthy | Phase 1 | 2020-10-16 |
| Completed | A Study of JNJ-77474462 in Healthy Participants Healthy | Phase 1 | 2020-10-13 |
| Active Not Recruiting | A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, i Carcinoma, Non-Small-Cell Lung | Phase 3 | 2020-10-13 |
| Active Not Recruiting | A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Carcinoma, Non-Small-Cell Lung | Phase 3 | 2020-09-30 |
| Completed | A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Dementia, Alzheimer Disease | — | 2020-09-28 |
| Active Not Recruiting | A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Pre Metastatic Castration-sensitive Prostate Cancer | Phase 3 | 2020-09-23 |
| Active Not Recruiting | A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma Hematological Malignancies | Phase 2 | 2020-09-17 |
| Completed | A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Vi Hepatitis D, Chronic | Phase 2 | 2020-09-17 |
| Completed | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major D Depressive Disorder, Major | Phase 3 | 2020-09-16 |
| Terminated | A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major D Depressive Disorder, Major | Phase 3 | 2020-09-15 |
| Completed | A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Depressive Disorder, Major | Phase 3 | 2020-09-15 |
| Terminated | A Study of Guselkumab in Participants With Active Lupus Nephritis Lupus Nephritis | Phase 2 | 2020-09-15 |
| Completed | A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 Hepatitis B, Chronic | Phase 2 | 2020-09-14 |
| Completed | A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants Healthy | Phase 1 | 2020-09-14 |
| Completed | A Study of Seltorexant in Healthy Participants Healthy | Phase 1 | 2020-09-14 |
| Completed | A Study of JNJ-64251330 in Healthy Participants Healthy | Phase 1 | 2020-09-02 |
| Completed | A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Un Prostatic Neoplasms | Phase 2 | 2020-08-19 |
| Terminated | A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants Renal Insufficiency | Phase 1 | 2020-08-19 |
| Terminated | A Study of JNJ-53718678 in Participants With Hepatic Impairment Hepatic Impairment | Phase 1 | 2020-08-17 |
| Terminated | A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Coronavirus Disease 2019 (COVID-19) | Phase 3 | 2020-08-13 |
| Completed | Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD Healthy | — | 2020-08-07 |
| Withdrawn | A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Healthy | Phase 2 | 2020-07-28 |
| Completed | A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Conce Healthy | Phase 1 | 2020-07-27 |
| Completed | A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants Healthy Participants | Phase 1 | 2020-07-20 |
| Completed | A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Par Depressive Disorder, Major | Phase 1 | 2020-07-16 |
| Completed | A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male Participants Healthy | Phase 1 | 2020-07-14 |
| Withdrawn | A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 3 | 2020-07-14 |
| Completed | A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors Neoplasms | Phase 1 | 2020-07-10 |
| Completed | A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | 2020-07-02 |
| Terminated | A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis Healthy, Colitis, Ulcerative | Phase 1 | 2020-07-01 |
| Completed | A Study of JNJ-70033093 in Healthy Participants Healthy | Phase 1 | 2020-06-26 |
| Completed | A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Partici Healthy | Phase 1 | 2020-06-19 |
| Active Not Recruiting | A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Poma Multiple Myeloma | Phase 3 | 2020-06-12 |
| Completed | A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants Uterine Hemorrhage | — | 2020-05-15 |
| Completed | A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure Heart Failure | Phase 3 | 2020-03-10 |
| Completed | A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Ba Urinary Bladder Neoplasms | Phase 2 | 2020-02-28 |
| Active Not Recruiting | A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for Multiple Myeloma | Phase 1 | 2020-02-21 |
| Completed | A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants Healthy | Phase 1 | 2020-02-18 |
| Completed | A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants Healthy | Phase 1 | 2020-02-11 |
| Completed | A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Par Healthy Participants | Phase 1 | 2020-01-17 |
| Completed | A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Part Healthy | Phase 1 | 2020-01-17 |
| Completed | A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants Healthy | Phase 1 | 2020-01-10 |
| Completed | A Study of JNJ-70033093 and Digoxin in Healthy Participants Healthy | Phase 1 | 2020-01-09 |
| Completed | A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma Multiple Myeloma | Phase 1 | 2019-12-25 |
| Completed | A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants Healthy | Phase 1 | 2019-12-20 |
| Completed | A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobuli Waldenstrom Macroglobulinemia | Phase 4 | 2019-12-18 |
| Completed | A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Particip Healthy | Phase 1 | 2019-12-18 |
| Completed | A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Part Healthy | Phase 1 | 2019-12-17 |
| Active Not Recruiting | A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CR Prostatic Neoplasms | Phase 4 | 2019-12-17 |
| Completed | A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) Hypertension, Pulmonary | EARLY_Phase 1 | 2019-12-16 |
| Completed | Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy C Healthy | Phase 1 | 2019-11-29 |
| Active Not Recruiting | A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Advanced Solid Tumor | Phase 2 | 2019-11-20 |
| Completed | A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal H Hepatic Impairment | Phase 1 | 2019-11-07 |
| Active Not Recruiting | A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Multiple Myeloma | Phase 2 | 2019-11-07 |
| Completed | A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants Healthy | Phase 1 | 2019-10-30 |
| Completed | A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatiti Atopic Dermatitis, Eczema | Phase 2 | 2019-10-16 |
| Completed | A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2019-10-16 |
| Completed | A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-5371867 Respiratory Syncytial Viruses | Phase 2 | 2019-10-10 |
| Completed | A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamph Attention Deficit Disorder With Hyperactivity | — | 2019-10-09 |
| Completed | A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Healthy | Phase 1 | 2019-10-08 |
| Completed | A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan Attention Deficit Disorder With Hyperactivity | — | 2019-10-01 |
| Active Not Recruiting | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis | Phase 2 / Phase 3 | 2019-09-26 |
| Terminated | A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 2 | 2019-09-23 |
| Completed | A Study of Paliperidone Palmitate 6-Month Formulation Schizophrenia | Phase 3 | 2019-09-19 |
| Completed | A Study of JNJ-61393215 in the Treatment of Depression Major Depressive Disorder With Anxious Distress | Phase 2 | 2019-09-17 |
| Completed | A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurat Hidradenitis Suppurativa, Acne Inversa, Suppurative Hidradenitis | Phase 2 | 2019-09-16 |
| Completed | A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Health Healthy | Phase 1 | 2019-09-16 |
| Completed | A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Healthy | Phase 1 | 2019-09-16 |
| Active Not Recruiting | A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-smal Carcinoma, Non-Small-Cell Lung | Phase 1 | 2019-09-04 |
| Active Not Recruiting | Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia Warm Autoimmune Hemolytic Anemia | Phase 2 / Phase 3 | 2019-08-15 |
| Terminated | A Study of Itraconazole in the Management of Superficial Fungal Infections in India Mycoses | Phase 4 | 2019-08-06 |
| Completed | A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations Urothelial Cancer, Receptors, Fibroblast Growth Factor | — | 2019-08-01 |
| Terminated | A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants Healthy | Phase 1 | 2019-07-29 |
| Completed | First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation Neoplasms, Advanced Solid Tumors, Non-small Cell Lung Cancer | Phase 1 | 2019-07-26 |
| Completed | A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologic HIV | Phase 2 | 2019-07-18 |
| Completed | A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginni Healthy | Phase 1 | 2019-07-12 |
| Completed | A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants Healthy | Phase 1 | 2019-06-24 |
| Completed | A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Arthroplasty, Replacement, Knee | Phase 2 | 2019-06-17 |
| Active Not Recruiting | A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are C Prostatic Neoplasms | Phase 3 | 2019-06-11 |
| Completed | A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health Extraintestinal Pathogenic Escherichia Coli Prevention | Phase 1 / Phase 2 | 2019-06-06 |
| Terminated | Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumuma Multiple Myeloma | Phase 2 | 2019-05-31 |
| Completed | A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Healthy | Phase 1 | 2019-05-15 |
| Completed | A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Gr Stroke | — | 2019-05-06 |
| Completed | A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors Neoplasms | Phase 1 | 2019-05-01 |
| Completed | A Safety and Tolerability Study of JNJ-72537634 in Healthy Participants Healthy | Phase 1 | 2019-04-30 |
| Active Not Recruiting | A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants Wi Multiple Myeloma | Phase 3 | 2019-04-26 |
| Completed | A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer Metastatic Prostate Cancer | — | 2019-04-22 |
| Completed | A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants Healthy | Phase 1 | 2019-04-09 |
| Completed | A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants Healthy | EARLY_Phase 1 | 2019-04-08 |
| Completed | A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CL Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | 2019-04-03 |
| Completed | A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodyspl Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | 2019-03-28 |
| Completed | Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcri Psoriasis Vulgaris | — | 2019-03-15 |
| Completed | A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult Participan Healthy | Phase 1 | 2019-02-13 |
| Active Not Recruiting | A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Pre Castration-Resistant Prostatic Cancer | Phase 3 | 2019-01-25 |
| Completed | A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN), Erythroblastosis, Fetal | — | 2019-01-16 |
| Completed | A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Particip Healthy | Phase 1 | 2019-01-11 |
| Completed | A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participa Sleep Apnea, Obstructive | Phase 1 | 2019-01-04 |
| Completed | A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants Healthy | Phase 1 | 2018-12-20 |
| Terminated | A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib Hepatic Impairment | Phase 1 | 2018-12-06 |
| Terminated | Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) Respiratory Syncytial Virus Infections | Phase 2 | 2018-11-29 |
| Completed | A Study for Schizophrenia Relapse Prediction Schizophrenia | — | 2018-11-29 |
| Completed | A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moder Colitis, Ulcerative | Phase 2 | 2018-11-20 |
| Completed | A Study of Guselkumab in Participants With Familial Adenomatous Polyposis Adenomatous Polyposis Coli | Phase 1 | 2018-11-19 |
| Completed | A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Particip Autism Spectrum Disorder | Phase 2 | 2018-11-07 |
| Active Not Recruiting | A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Len Multiple Myeloma | Phase 3 | 2018-11-06 |
| Withdrawn | Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimen Metapneumovirus | Phase 2 | 2018-11-05 |
| Active Not Recruiting | A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely A Colitis, Ulcerative | Phase 3 | 2018-10-29 |
| Completed | A Study to Evaluate the Safety and Tolerability of JNJ-67670187 in Healthy Participants Healthy | Phase 1 | 2018-10-25 |
| Completed | A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate i Schizophrenia | Phase 4 | 2018-10-18 |
| Terminated | A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupa Healthy | Phase 1 | 2018-10-17 |
| Completed | A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Partici Healthy | Phase 1 | 2018-10-02 |
| Completed | A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants Healthy | Phase 1 | 2018-10-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Lepros Leprosy, Multibacillary | Phase 2 | 2018-09-26 |
| Terminated | A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Human Immunodeficiency Virus Infections | Phase 3 | 2018-09-24 |
| Completed | AAVCAGsCD59 for the Treatment of Wet AMD Wet Age-related Macular Degeneration | Phase 1 | 2018-09-13 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants Wit Hidradenitis Suppurativa | Phase 2 | 2018-09-04 |
| Active Not Recruiting | A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Re Prostatic Neoplasms | Phase 1 | 2018-08-31 |
| Completed | A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy Participants Healthy | Phase 1 | 2018-08-28 |
| Completed | A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Parti Healthy | Phase 1 | 2018-07-31 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Fema Healthy | Phase 1 | 2018-07-31 |
| Completed | A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression Depressive Disorder, Major | Phase 2 | 2018-07-16 |
| Completed | A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared W Healthy | Phase 1 | 2018-07-13 |
| Completed | A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk Neoplasms, Solid Tumor, Adult, Non-Hodgkin Lymphoma | Phase 1 | 2018-07-13 |
| Completed | A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Healthy | Phase 1 | 2018-07-11 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for t Psoriasis | Phase 3 | 2018-07-11 |
| Completed | A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Multiple Myeloma | Phase 1 / Phase 2 | 2018-06-29 |
| Completed | A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Hea Obesity | Phase 1 | 2018-06-29 |
| Completed | A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Com Castration-Resistant Prostatic Neoplasms | Phase 1 | 2018-06-28 |
| Completed | A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabete Obesity and Diabetes Mellitus, Type 2 | Phase 2 | 2018-06-26 |
| Completed | A Study of Bermekimab in Patients With Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2018-06-20 |
| Completed | A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in H Healthy | Phase 1 | 2018-06-12 |
| Completed | A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Ren Kidney Failure, Chronic | Phase 1 | 2018-06-06 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Hea Healthy | Phase 1 | 2018-06-01 |
| Completed | Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat) Alzheimer Disease | EARLY_Phase 1 | 2018-05-30 |
| Completed | A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Es Depressive Disorder, Treatment-Resistant | Phase 3 | 2018-05-25 |
| Completed | A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2018-05-21 |
| Completed | Fluoroquinolone Associated Disability Bronchitis, Sinusitis, Urinary Tract Infections | — | 2018-05-17 |
| Completed | A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater T Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | 2018-05-14 |
| Completed | A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscu Healthy | Phase 2 | 2018-05-09 |
| Completed | A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens Multiple Myeloma | Phase 2 | 2018-04-26 |
| Active Not Recruiting | A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-li Leukemia, Lymphocytic, Chronic, B-Cell | Phase 3 | 2018-04-17 |
| Terminated | A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 3 | 2018-04-16 |
| Active Not Recruiting | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Di Crohn's Disease | Phase 2 / Phase 3 | 2018-04-13 |
| Completed | A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Par Healthy | Phase 1 | 2018-04-09 |
| Active Not Recruiting | A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer Urothelial Carcinoma | Phase 1 / Phase 2 | 2018-04-05 |
| Completed | A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregna Hemolytic Disease of the Fetus and Newborn | Phase 2 | 2018-04-05 |
| Completed | A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants Obesity | Phase 2 | 2018-03-26 |
| Active Not Recruiting | A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Ur Urothelial Cancer | Phase 3 | 2018-03-23 |
| Terminated | A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a S Healthy | Phase 1 | 2018-03-06 |
| Active Not Recruiting | A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cance Prostatic Neoplasms, Castration-Resistant | Phase 2 | 2018-03-02 |
| Completed | A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failu Diabetes Mellitus, Type 2, Cardiovascular Diseases | — | 2018-02-22 |
| Completed | A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinet Healthy | Phase 1 | 2018-02-09 |
| Completed | A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Healthy | Phase 1 | 2018-02-09 |
| Completed | A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JN Respiratory Syncytial Virus Infections | Phase 2 | 2018-02-06 |
| Terminated | A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Mai Crohn Disease, Ulcerative Colitis | Phase 1 | 2018-02-02 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Influenza A | Phase 3 | 2018-01-21 |
| Completed | A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depre Depressive Disorder, Major | Phase 1 | 2018-01-05 |
| Completed | A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing Respiratory Syncytial Virus Infections | Phase 2 | 2018-01-05 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Influenza A | Phase 3 | 2018-01-03 |
| Completed | A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healt Healthy | Phase 1 | 2018-01-02 |
| Terminated | An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combi Adenocarcinoma of Lung | Phase 1 / Phase 2 | 2018-01-02 |
| Completed | A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healt Alzheimer Disease | Phase 1 | 2017-12-22 |
| Active Not Recruiting | Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma Hematological Malignancies | Phase 1 | 2017-12-16 |
| Completed | A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release a Depressive Disorder, Major | Phase 2 | 2017-12-12 |
| Completed | A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Ch Multiple Myeloma | Phase 3 | 2017-11-30 |
| Terminated | A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of O Respiratory Syncytial Viruses | Phase 2 | 2017-11-24 |
| Completed | A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D- Multiple Myeloma | Phase 3 | 2017-11-23 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disor Insomnia Disorders | Phase 2 | 2017-11-23 |
| Completed | A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible Urinary Bladder Neoplasms | Phase 1 | 2017-11-20 |
| Completed | A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting | — | 2017-11-20 |
| Completed | A Study of Paliperidone Palmitate 6-Month Formulation Schizophrenia | Phase 3 | 2017-11-20 |
| Completed | A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Dara Multiple Myeloma | Phase 2 / Phase 3 | 2017-11-16 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants Healthy | Phase 1 | 2017-11-15 |
| Completed | A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants U VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery | Phase 2 | 2017-11-13 |
| Active Not Recruiting | A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multipl Smoldering Multiple Myeloma | Phase 3 | 2017-11-07 |
| Completed | A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed o Multiple Myeloma | Phase 3 | 2017-10-27 |
| Completed | An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants Wit Diabetes Mellitus, Type 2 | Phase 4 | 2017-10-27 |
| Completed | A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 | 2017-10-20 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab Healthy | Phase 1 | 2017-10-16 |
| Completed | A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Pre-Symptomatic Type 1 Diabetes | Phase 1 | 2017-10-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib an Amyloidosis | Phase 3 | 2017-10-05 |
| Completed | Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensi Depressive Disorder, Major | Phase 2 | 2017-10-05 |
| Completed | A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Healthy | Phase 1 | 2017-09-26 |
| Completed | A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly S Healthy | Phase 4 | 2017-09-20 |
| Completed | A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-6451107 Healthy | Phase 1 | 2017-09-12 |
| Withdrawn | A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Com Hepatic Impairment | Phase 1 | 2017-09-11 |
| Completed | Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participan Alzheimer Disease | EARLY_Phase 1 | 2017-09-06 |
| Completed | A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Acti Arthritis, Psoriatic | Phase 3 | 2017-08-24 |
| Completed | A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Depressive Disorder, Major | Phase 2 | 2017-08-16 |
| Completed | A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JN Diabetes Mellitus, Type 2 | Phase 1 | 2017-08-01 |
| Completed | Long-term Follow-up Gene Therapy Study for RPGR- XLRP X-Linked Retinitis Pigmentosa | — | 2017-07-31 |
| Completed | A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years Diabetes Mellitus, Type 2 | Phase 3 | 2017-07-21 |
| Completed | A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Acti Arthritis, Psoriatic | Phase 3 | 2017-07-12 |
| Withdrawn | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With System Lupus Erythematosus, Systemic | Phase 1 | 2017-06-30 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-6417 Healthy | Phase 1 | 2017-06-27 |
| Completed | 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehen Depressive Disorder, Major | Phase 3 | 2017-06-15 |
| Completed | 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehen Depressive Disorder, Major | Phase 3 | 2017-06-09 |
| Terminated | A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healt Healthy | Phase 1 | 2017-05-30 |
| Terminated | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Healthy | Phase 1 | 2017-05-17 |
| Completed | A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Alzheimer Disease | Phase 1 | 2017-05-17 |
| Active Not Recruiting | Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed Hematological Malignancies | Phase 1 / Phase 2 | 2017-05-16 |
| Completed | A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir a Healthy | Phase 1 | 2017-05-12 |
| Completed | A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Mo Psoriasis | Phase 3 | 2017-04-27 |
| Completed | A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpiviri Healthy | Phase 1 | 2017-04-20 |
| Completed | A Study to Evaluate the Effect of Fluconazole and Itraconazole on Erdafitinib Pharmacokinetics in Healthy Adul Healthy | Phase 1 | 2017-04-14 |
| Completed | Optimizing Clinical Screening and Management of Maternal Mental Health: Predicting Women at Risk for Perinatal Depression | — | 2017-04-14 |
| Terminated | A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Femal Healthy | Phase 1 | 2017-04-13 |
| Terminated | A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containin Hepatitis C | Phase 3 | 2017-04-10 |
| Completed | Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 Dry Age-related Macular Degeneration | Phase 1 | 2017-03-29 |
| Completed | A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2 Healthy | Phase 1 | 2017-03-14 |
| Completed | A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants Healthy | Phase 1 | 2017-03-14 |
| Completed | Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type P Psoriasis | Phase 3 | 2017-02-28 |
| Terminated | Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and Healthy | Phase 1 | 2017-02-20 |
| Completed | A Pharmacokinetic Study of MABp1 in Healthy Volunteers Healthy | Phase 1 | 2017-02-15 |
| Completed | A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Lymphoma | Phase 2 | 2017-02-14 |
| Completed | Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Depend Myelodysplastic Syndromes | Phase 2 | 2017-02-14 |
| Completed | A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulat Healthy | Phase 1 | 2017-02-06 |
| Completed | A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose Healthy | Phase 1 | 2017-01-26 |
| Completed | Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, HIV-1 | Phase 1 | 2017-01-23 |
| Completed | A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Diseas Crohn Disease | Phase 1 | 2017-01-18 |
| Completed | A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Sin Healthy | Phase 1 | 2017-01-17 |
| Completed | An Epidemiology Study of Treatment Resistant Depression in the United States (US) Depressive Disorder, Treatment-Resistant | — | 2017-01-15 |
| Completed | A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healt Healthy | Phase 1 | 2017-01-01 |
| Completed | A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2016-12-23 |
| Withdrawn | Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Fo Healthy | Phase 1 | 2016-11-22 |
| Active Not Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Neoplasms | Phase 1 / Phase 2 | 2016-11-21 |
| Completed | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatri Thrombosis | Phase 3 | 2016-11-16 |
| Completed | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-641793 Healthy | Phase 1 | 2016-11-14 |
| Completed | A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprev Healthy | Phase 1 | 2016-11-10 |
| Completed | A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir Renal Insufficiency | Phase 1 | 2016-11-09 |
| Completed | Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chroni Hepatitis C, Chronic | Phase 2 | 2016-11-09 |
| Completed | A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Conc Healthy | Phase 1 | 2016-11-08 |
| Completed | Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Te Depressive Disorder, Major | — | 2016-10-26 |
| Terminated | Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Ora Respiratory Syncytial Viruses | Phase 2 | 2016-10-25 |
| Completed | A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar D Bipolar Disorder | — | 2016-10-25 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Maj Depressive Disorder, Major | Phase 1 | 2016-10-17 |
| Completed | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Pa Healthy | Phase 1 | 2016-10-12 |
| Completed | A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Depressive Disorder, Major | Phase 1 | 2016-10-07 |
| Completed | A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metast Prostatic Neoplasms | Phase 1 | 2016-10-03 |
| Withdrawn | A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunoth Prostatic Neoplasms, Castration-Resistant | Phase 2 | 2016-10-01 |
| Completed | A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a S Healthy | Phase 1 | 2016-10-01 |
| Completed | Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relap Multiple Myeloma | Phase 3 | 2016-09-27 |
| Completed | Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multip Multiple Myeloma | Phase 1 | 2016-09-26 |